Fig. 3

IGFBP-3 expression influences overall survival of ESCC patients. High expression of IGFBP-3 in 70 ESCC patients treated with radiotherapy alone was associated with prolonged a overall survival and b progression-free survival (P < 0.001; log-rank test)